These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21190089)

  • 21. [Alpha fetoprotein and HbF cells in the maternal blood and their modification through amniocentesis].
    Maas DH; Hoppe B; Weitzel HK
    Fortschr Med; 1979 Jun; 97(21):981-6. PubMed ID: 86491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of feto-maternal haemorrhage after genetic amniocentesis.
    Gigli C; Leopardi A; Casaccia R; Fischer-Tamaro L; Mandruzzato GP
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):118-20. PubMed ID: 2480408
    [No Abstract]   [Full Text] [Related]  

  • 23. The relation between maternal serum alpha-fetoprotein levels and fetomaternal haemorrhage.
    Hay DL; Barrie JU; Davison GB; Buttery BW; Horacek I; Pepperell RJ; Fliegner JR
    Br J Obstet Gynaecol; 1979 Jul; 86(7):516-20. PubMed ID: 89863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetomaternal bleeding following diagnostic amniocentesis.
    Lele AS; Carmody PJ; Hurd ME; O'Leary JA
    Obstet Gynecol; 1982 Jul; 60(1):60-4. PubMed ID: 6178064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk and grade of feto-maternal hemotransfusion during early amniocentesis].
    Spiazzi L; De Sabata D; Tommasoli RM; Zardini E
    Minerva Ginecol; 1986 Nov; 38(11):889-94. PubMed ID: 2433644
    [No Abstract]   [Full Text] [Related]  

  • 26. Risks of fetomaternal hemorrhage resulting from amniocentesis with and without ultrasound placental localization.
    Harrison R; Campbell S; Craft I
    Obstet Gynecol; 1975 Oct; 46(4):389-91. PubMed ID: 1165872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Frequency and importance of fetomaternal hemorrhages through early amniocentesis].
    Sender A; Pinon F; Maigret P; Henrion R; Chavinie J; Van Nifterik J
    Rev Fr Transfus Immunohematol; 1975 Dec; 18(4):373-84. PubMed ID: 819979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On the feto-maternal transfusion of red blood cells during transplacental and para-placental genetic amniocenteses (author's transl)].
    Zach HP; Zahn V; Herzog B; Stühmer M
    Geburtshilfe Frauenheilkd; 1979 May; 39(5):378-83. PubMed ID: 456859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alpha fetoprotein and HbF cells in maternal blood in amniocenteses].
    Maas DH; Hoppe B; Weitzel H
    Arch Gynecol; 1979 Jul; 228(1-4):201. PubMed ID: 90482
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fetomaternal micro-passage of AFP and early amniocentesis].
    Nguyen The H; Pescia G; De Grandi P
    Rev Med Suisse Romande; 1981 Nov; 101(11):891-4. PubMed ID: 6172826
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fetomaternal transfusions in early pregnancy].
    du Bois A; Rasenack R; Siebers JW; Geyer H; Quaas L
    Z Geburtshilfe Perinatol; 1991; 195(2):71-5. PubMed ID: 1716034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chorionic villi sampling changes maternal serum alpha-fetoprotein.
    Mariona FG; Bhatia R; Syner FN; Koppitch F
    Prenat Diagn; 1986; 6(1):69-73. PubMed ID: 2419892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevation of maternal alpha-fetoprotein serum levels in relation to fetomaternal haemorrhage after second trimester pregnancy termination by aspirotomy.
    Bennebroek Gravenhorst J; Beintema-Dubbeldam A; van Lith DA; Beekhuizen W
    Br J Obstet Gynaecol; 1986 Dec; 93(12):1302-4. PubMed ID: 2432919
    [No Abstract]   [Full Text] [Related]  

  • 34. Fetomaternal haemorrhage treated with intravascular transfusion: a late complication of amniocentesis?
    Kohlenberg CF; Ellwood DA
    Br J Obstet Gynaecol; 1994 Oct; 101(10):912-3. PubMed ID: 7999699
    [No Abstract]   [Full Text] [Related]  

  • 35. Transabdominal chorionic villus sampling in the second trimester of pregnancy: feto-maternal transfusions in relation to pregnancy outcome.
    Los FJ; Pijpers L; Jahoda MG; Sachs ES; Reuss A; Hagenaars AM; Wladimiroff JW
    Prenat Diagn; 1989 Jul; 9(7):521-6. PubMed ID: 2475867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Massive fetomaternal hemorrhage: Manitoba experience.
    de Almeida V; Bowman JM
    Obstet Gynecol; 1994 Mar; 83(3):323-8. PubMed ID: 8127519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplacental needle passage and other risk-factors associated with second trimester amniocentesis.
    Marthin T; Liedgren S; Hammar M
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):728-32. PubMed ID: 9348248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application and evaluation of invasive prenatal diagnostic techniques and analysis of chromosomal karyotype].
    Wang L; Wang X; Zhang S; Zhou Z; Zhu F; Ding Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):400-4. PubMed ID: 23645241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antenatal care in pregnancies at risk of alloimmune thrombocytopenia: report of 19 cases in 16 families.
    Kanhai HH; Porcelijn L; van Zoeren D; Klumper F; Viëtor H; Meerman RH; Brand A
    Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):67-73. PubMed ID: 8886684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fetomaternal transfusion depends on amount of chorionic villi aspirated but not on method of chorionic villus sampling.
    Shulman LP; Meyers CM; Simpson JL; Andersen RN; Tolley EA; Elias S
    Am J Obstet Gynecol; 1990 May; 162(5):1185-8. PubMed ID: 1692666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.